DOI: 10.1055/s-00023610

Drug Research

LinksSchließen

Referenz

Kosiborod M, Cavender MA, Fu AZ. et al.
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).

Circulation 2017;
136: 249-259

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in:
Aufrufen in: